These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34966100)

  • 1. Considerations in Methods and Timing for Delivery of Genetic Counseling Information to Pediatric Oncology Patients and Families.
    Li KA; Sloat LM; Kung J; Jung J; Li A; Smith CH; Schratz KE; Cooper SL; Pratilas CA; Frankenfield P; Bodurtha J
    J Pediatr Hematol Oncol; 2022 Aug; 44(6):313-317. PubMed ID: 34966100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating genetic counseling and testing in the pediatric oncology setting: Parental attitudes and influencing factors.
    Desrosiers LR; Quinn E; Cramer S; Dobek W
    Pediatr Blood Cancer; 2019 Oct; 66(10):e27907. PubMed ID: 31294517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Counselor Recommendations for Cancer Predisposition Evaluation and Surveillance in the Pediatric Oncology Patient.
    Druker H; Zelley K; McGee RB; Scollon SR; Kohlmann WK; Schneider KA; Wolfe Schneider K
    Clin Cancer Res; 2017 Jul; 23(13):e91-e97. PubMed ID: 28674117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline whole genome sequencing in pediatric oncology in Denmark-Practitioner perspectives.
    Byrjalsen A; Stoltze UK; Castor A; Wahlberg A
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1276. PubMed ID: 32500610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "I remember how I felt, but I don't remember the gene": Families' experiences of cancer-related genetic testing in childhood.
    McGill BC; Wakefield CE; Vetsch J; Lim Q; Warby M; Metcalfe A; Byrne JA; Cohn RJ; Tucker KM
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27762. PubMed ID: 31006986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timing of referral for genetic counseling and genetic testing in patients with ovarian, fallopian tube, or primary peritoneal carcinoma.
    Novetsky AP; Smith K; Babb SA; Jeffe DB; Hagemann AR; Thaker PH; Powell MA; Mutch DG; Massad LS; Zighelboim I
    Int J Gynecol Cancer; 2013 Jul; 23(6):1016-21. PubMed ID: 23748176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996.
    J Clin Oncol; 1996 May; 14(5):1730-6; discussion 1737-40. PubMed ID: 8622094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining the role of a genetic counselor within pediatric hematology and oncology comprehensive care teams: Perspectives of the provider team and patients.
    Hudson P; Zajo K; Gerhardt CA; Stanek J; Varga E
    J Genet Couns; 2019 Dec; 28(6):1139-1147. PubMed ID: 31478312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of a genetic counselor: improving identification of cancer genetic counseling patients with chart review.
    Eichmeyer JN; Burnham C; Sproat P; Tivis R; Beck TM
    J Genet Couns; 2014 Jun; 23(3):323-9. PubMed ID: 24155015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporating genetic counseling into clinical care for children and adolescents with cancer.
    Everett JN; Mody RJ; Stoffel EM; Chinnaiyan AM
    Future Oncol; 2016 Apr; 12(7):883-6. PubMed ID: 26888175
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer Genetic Counseling-Current Practice and Future Challenges.
    Schienda J; Stopfer J
    Cold Spring Harb Perspect Med; 2020 Jun; 10(6):. PubMed ID: 31548230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of barriers to referral for cancer predisposition syndromes in pediatric oncology patients in the United States.
    Venier RE; Grubs RE; Kessler E; Cooper KL; Bailey KM; Meade J
    J Genet Couns; 2022 Aug; 31(4):901-911. PubMed ID: 35147246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Key messages for communicating information about BRCA1 and BRCA2 to women with breast or ovarian cancer: Consensus across health professionals and service users.
    Jacobs C; Pichert G; Harris J; Tucker K; Michie S
    Psychooncology; 2017 Nov; 26(11):1818-1824. PubMed ID: 28101941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Will cancer risk assessment and counseling services survive genetic testing?
    Kelly PT
    Acta Oncol; 1999; 38(6):743-6. PubMed ID: 10522764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The current state of cancer genetic counseling access and availability.
    Knapke S; Haidle JL; Nagy R; Pirzadeh-Miller S
    Genet Med; 2016 Apr; 18(4):410-2. PubMed ID: 26248009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on Genetic Counselor Practice and Recommendations for Pediatric Cancer Predisposition Evaluation and Surveillance.
    Zelley K; Schienda J; Gallinger B; Kohlmann WK; McGee RB; Scollon SR; Schneider KW
    Clin Cancer Res; 2024 Sep; 30(18):3983-3989. PubMed ID: 39037753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Counseling and Testing in a Community Setting: Quality, Access, and Efficiency.
    Cohen SA; Bradbury A; Henderson V; Hoskins K; Bednar E; Arun BK
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():e34-e44. PubMed ID: 31099680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embedding a genetic counselor into oncology clinics improves testing rates and timeliness for women with ovarian cancer.
    Rana HQ; Kipnis L; Hehir K; Cronin A; Jaung T; Stokes SM; Fekrmandi F; Vatnick D; Matulonis UA; Garber JE; Wright AA
    Gynecol Oncol; 2021 Feb; 160(2):457-463. PubMed ID: 33229043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ownership of uncertainty: healthcare professionals counseling and treating women from hereditary breast and ovarian cancer families who receive an inconclusive BRCA1/2 genetic test result.
    Kenen R; Ardern-Jones A; Lynch E; Eeles R
    Genet Test Mol Biomarkers; 2011 Apr; 15(4):243-50. PubMed ID: 21254913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.